Guihui Wu

机构：South China Normal University

发表论文 51 篇 · 总被引 522 次 · h-index 10

代表论文

• Impact of diabetes itself and glycemic control status on tuberculosis (2023 · Frontiers in Endocrinology · 被引 13)
• Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China (2024 · BMC Medicine · 被引 11)
• Predictors of early and interim culture un-conversion in multidrug-resistant/rifampicin-resistant tuberculosis: a retrospective multi-center cohort study in China (2024 · Antimicrobial Resistance and Infection Control · 被引 8)
• Treatment Outcomes and Associated Influencing Factors Among Patients with Rifampicin-Resistant Tuberculosis: A Multicenter, Retrospective, Cohort Study in China (2024 · Infection and Drug Resistance · 被引 6)
• Early bactericidal activity of sitafloxacin against pulmonary tuberculosis (2024 · Microbiology Spectrum · 被引 5)
• Epidemiology of tuberculosis and HIV coinfection among inpatients in chengdu, china, 2018–2022 (2025 · BMC Infectious Diseases · 被引 4)